Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Moderna
Biotech
Vertex takes $379M hit tied to cancelled islet cell program
Vertex announced a $379 million impairment charge tied to its earlier discontinuation of a clinical-stage islet cell treatment for diabetes.
Gabrielle Masson
May 6, 2025 12:50pm
Moderna's flu/COVID vaccine hit by deprioritization, FDA delay
May 1, 2025 7:24am
FDA rocked by leadership shake-ups—Chutes & Ladders
Apr 4, 2025 8:30am
Cell and gene company ElevateBio lays off 17% of staff
Mar 26, 2025 1:08pm
'Highly unlikely' BARDA will pull bird flu vax funding: Arcturus
Mar 7, 2025 10:24am
HHS reevaluates $590M bird flu deal with Moderna: report
Feb 27, 2025 11:07am